Skip to content

Stryker Corporation Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

Stryker Corporation · E.SYK.NYSE · United States
Use symbol E.SYK.NYSE in our API & Excel add-in to retrieve this data ↓
311.75
(+0.03%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 25%
Bubble Risk LOW
Realised Volatility (20D) 28.97%

Stryker Corporation Forecast

Stryker Corporation short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is positive (5 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 29.0% a year, a typical one-standard-deviation range is 299.03–324.47 over a week, 285.67–337.83 over a month and 221.42–402.08 over a year. (Signals as of 1 Nov 2026.)

Stryker Corporation Price Chart

MacroFinance.ai

Stryker Corporation Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Stryker Corporation
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Stryker Corporation
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Stryker Corporation
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Stryker Corporation
P/E
33.10x
Cheap vs own history
QoQ −2.9%
YoY −31.6%
now 33.102528.19 low48.77 high
ⓘP/E As of 22 Nov 2026.See Stryker Corporation returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Stryker Corporation
P/S
4.56x
Cheap vs own history
QoQ −7.4%
YoY −21.9%
now 4.56014.07 low5.96 high
ⓘP/S As of 22 Nov 2026.See Stryker Corporation returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Stryker Corporation
P/B
5.11x
Cheap vs own history
QoQ −3.6%
YoY −21.8%
now 5.11284.38 low6.68 high
ⓘP/B As of 22 Nov 2026.See Stryker Corporation returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Stryker Corporation
EV/EBITDA
19.95x
Cheap vs own history
QoQ −3.7%
YoY −38.7%
now 19.950517.42 low32.79 high
ⓘEV/EBITDA As of 22 Nov 2026.See Stryker Corporation returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Stryker Corporation
EV/Sales
5.02x
Cheap vs own history
QoQ −6.4%
YoY −21.8%
now 5.02254.51 low6.47 high
ⓘEV/Sales As of 22 Nov 2026.See Stryker Corporation returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Stryker Corporation
FCF Yield
3.8%
Strong vs own history
QoQ +3.1%
YoY +33.3%
now 3.81312.84 low4.47 high
ⓘFCF Yield As of 22 Nov 2026.See Stryker Corporation returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Stryker Corporation
Earnings Yield
3.0%
Strong vs own history
QoQ +3.0%
YoY +46.2%
now 3.02092.05 low3.55 high
ⓘEarnings Yield As of 22 Nov 2026.See Stryker Corporation returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Stryker Corporation
Dividend Yield
1.1%
Strong vs own history
QoQ +7.3%
YoY +24.8%
now 1.11150.86 low1.25 high
ⓘDividend Yield As of 22 Nov 2026.See Stryker Corporation returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Stryker Corporation
Market Cap
$119.9B
Mid-range vs own history
QoQ −5.7%
YoY −15.8%
now 119930.225105,131 low149,753 high
ⓘMarket Cap As of 22 Nov 2026.See Stryker Corporation returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Stryker Corporation
Net Debt
$12.2B
Mid-range vs own history
QoQ +6.1%
YoY −14.2%
now 1216211,466 low14,167 high
ⓘNet Debt As of 22 Nov 2026.See Stryker Corporation returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Stryker Corporation
Net Debt / EBITDA
1.84x
Low vs own history
QoQ +7.2%
YoY −37.6%
now 1.83691.71 low2.95 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Stryker Corporation returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Stryker Corporation
Current Ratio
2.18x
Strong vs own history
QoQ +1.2%
YoY +18.0%
now 2.1821.85 low2.18 high
ⓘCurrent Ratio As of 22 Nov 2026.See Stryker Corporation returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Stryker Corporation
Quick Ratio
1.30x
Mid-range vs own history
QoQ −2.5%
YoY +15.4%
now 1.29781.13 low1.33 high
ⓘQuick Ratio As of 22 Nov 2026.See Stryker Corporation returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Stryker Corporation
Interest Coverage
6.66x
Mid-range vs own history
QoQ +1.1%
YoY —
now 6.65935.79 low6.66 high
ⓘInterest Coverage As of 22 Nov 2026.See Stryker Corporation returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Stryker Corporation
Debt / Equity
0.66x
Mid-range vs own history
QoQ +5.6%
YoY −18.1%
now 0.65790.62 low0.8 high
ⓘDebt / Equity As of 22 Nov 2026.See Stryker Corporation returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Stryker Corporation
Piotroski F-Score
9
Strong vs own history
QoQ +12.5%
YoY +125.0%
now 94 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Stryker Corporation returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Stryker Corporation
Altman Z-Score
4.78
Mid-range vs own history
QoQ −3.0%
YoY −2.5%
now 4.78434.24 low5.17 high
ⓘAltman Z-Score As of 22 Nov 2026.See Stryker Corporation returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Stryker Corporation, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Stryker Corporation fundamentals: income statement, balance sheet & cash flow

Stryker Corporation reported revenue of $25.12bn and net income of $3.25bn in FY2025, the year ended 31 December 2025 — revenue up 11.2% and net income up 8.5% on the prior year. Free cash flow was $4.28bn. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$25.12bn
+11.2%
Net income
$3.25bn
+8.5%
Gross margin
63.96%
Free cash flow
$4.28bn
+22.8%
Net debt
$12.35bn
Shares short (30 Oct 2026)
6.66m
2.23 days to cover
Stryker Corporation income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue25.1222.6020.5018.4517.11
Cost of revenue9.058.058.007.416.40
Gross profit16.0714.5512.4911.0410.71
Research & development1.581.471.291.231.13
Selling, general & admin.———6.04—
Operating income4.893.694.283.733.76
EBITDA6.316.015.064.023.61
Interest expense0.610.400.360.340.34
Pre-tax income4.513.493.672.682.28
Income tax1.270.500.510.330.29
Net income3.252.993.172.361.99

Download Stryker Corporation fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.SYK.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Stryker Corporation

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Stryker Corporation Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Stryker Corporation; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Stryker Corporation’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Stryker Corporation behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Stryker Corporation (United States)

Stryker Corporation is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on STRYKER (SYK.SG)

Frequently asked questions

What is Stryker Corporation?
Stryker Corporation is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Stryker Corporation price?
The latest close is 311.75 (1 Nov 2026), +0.03% on the day. The price at the top of the page refreshes during the trading day.
Is Stryker Corporation in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (5 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Stryker Corporation?
20-day realised volatility is 29.0% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 8.4% over a month and 4.1% over a week.
What factors affect Stryker Corporation?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Stryker Corporation, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Stryker Corporation?
58 backtested tactical asset allocation strategies trade Stryker Corporation through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Stryker Corporation returns analysed?
The Statistical Distribution of Returns section shows the distribution of Stryker Corporation daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Stryker Corporation historical data?
In the Free historical data section of this page: the last 10 years of Stryker Corporation daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Stryker Corporation historical data (last 10 years)

Browse or instantly download the last 10 years of Stryker Corporation daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SYK.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20310
2026-11-19313.08
2026-11-18318.15
2026-11-17317.54
2026-11-16310.72
2026-11-13309.64
2026-11-12312.39
2026-11-11318.79
2026-11-10324.29
2026-11-09325.73
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.